Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak.
Watch this animation and look inside a rapid test to see how lateral flow diagnostic technology works.
Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering.
Learn about some of the technical considerations for selecting antibodies during lateral flow assay development.
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project.
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market.
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.
“Early adopters such as triathletes are at the pointy end of this drive towards consumer health diagnostics.”
A few considerations to think about when wanting to maximise profit for your lateral flow rapid test.
What barriers can be broken down to aid recruitment and retention of clinical trial volunteers?
Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs?